Cost-Effectiveness of Coronary Artery Bypass Grafts Versus Percutaneous Coronary Intervention for Revascularization of High-Risk Patients

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Circulation

• Publication date

  2006-09-19

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1161/CIRCULATIONAHA.105.570838PMID 16966588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cost-effectiveness in health and medicine

  2016influential reference
• An Introduction to the Bootstrap

  2007cited by this paper
• Minimal structures , generalized topologies , and ascending systems should not be studied without generalized uniformities

  2007cited by this paper
• Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).

  2005cited by this paper
• Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

  2005cited by this paper
• Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial

  2004influential reference
• One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial

  2004cited by this paper
• Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).

  2004cited by this paper
• Long-Term Outcome in Elderly Patients With Chronic Angina Managed Invasively Versus by Optimized Medical Therapy: Four-Year Follow-Up of the Randomized Trial of Invasive Versus Medical Therapy in Elderly Patients (TIME)

  2004cited by this paper
• Cardiac revascularization of the medically refractory elderly patient: it is TIME to pay the piper.

  2004cited by this paper
• Average Cost of VA Rehabilitation, Mental Health, and Long-Term Hospital Stays

  2003cited by this paper
• Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial.

  2003cited by this paper
• Estimating the Costs of VA Ambulatory Care

  2003cited by this paper
• Using Average Cost Methods to Estimate Encounter-Level Costs for Medical-Surgical Stays in the VA

  2003cited by this paper
• A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes.

  2003influential reference
• Determination of VA Health Care Costs

  2003cited by this paper
• Economic Comparisons of Coronary Angioplasty and Coronary Bypass Surgery

  2003cited by this paper
• Members’ Perceptions of Community Care Network Partnerships’ Effectiveness

  2003cited by this paper
• Health-related quality of life after percutaneous coronary intervention versus coronary bypass surgery in high-risk patients with medically refractory ischemia.

  2003cited by this paper
• A primer and comparative review of major US mortality databases.

  2002cited by this paper
• Medical economics and the assessment of value in cardiovascular medicine: Part II.

  2002cited by this paper
• Cost-Effectiveness of a Conservative, Ischemia-Guided Management Strategy After Non–Q-Wave Myocardial Infarction: Results of a Randomized Trial

  2002cited by this paper
• Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: The VA AWESOME multicenter registry: comparison with the randomized clinical trial.

  2002cited by this paper
• Medical economics and the assessment of value in cardiovascular medicine: Part I.

  2002cited by this paper
• Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

  2001cited by this paper
• Trial of invasive versus medical therapy in elderly patients with chronic symptomatic coronary-artery disease (TIME): a randomised trial.

  2001cited by this paper
• Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th

  2001cited by this paper
• APCs: reimbursement implications.

  2000cited by this paper
• Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy

  2000cited by this paper
• A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients. The AWESOME (Veterans Affairs Cooperative Study #385, angina with extremely serious operative mortality evaluation) investigators from the Cooperative Studies Program of

  1999cited by this paper
• Myocardial revascularization in 1997: angioplasty versus bypass surgery.

  1997cited by this paper
• Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators.

  1997cited by this paper
• Three-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI).

  1996cited by this paper
• In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators.

  1995cited by this paper
• Medicare physician fees overhauled. The RBRVS fee system and its implications for hospitals.

  1992cited by this paper
• Medicare physician fees overhauled. The RBRVS fee system and its implications for hospitals.

  1992cited by this paper
• Initial report of the Veterans Administration Preoperative Risk Assessment Study for Cardiac Surgery.

  1990cited by this paper

• Resource Utilization and Costs Associated With Cardiogenic Shock Complicating Myocardial Infarction

  2024cites this paper
• Cost-effectiveness analysis of initial nonoperative management versus emergency laparoscopic appendectomy for acute complicated appendicitis in Japan

  2020cites this paper
• Evaluation of Quality of Life, Cognition and Endurance in Cardiac Procedures Patients

  2020cites this paper
• Evaluation of Tpeak to end/QT and Tpeak to end/QTc ratios in patients with STEMI undergoing percutaneous intervention vs. thrombolytic therapy.

  2019cites this paper
• State control and doctors’ abuse of clinical autonomy: An empirical analysis of doctors’ clinical practice in Chinese public hospitals

  2019cites this paper
• The Registered Nurse Surgical First Assistant (RNSFA) in Adult Cardiac Surgery.

  2019cites this paper
• Quality of health economic evaluations for the ACC/AHA stable ischemic heart disease practice guideline: A systematic review

  2018cites this paper
• Outcome‐based ventilation: A framework for assessing performance, health, and energy impacts to inform office building ventilation decisions

  2018cites this paper
• Interplay of ventilation and filtration: Differential analysis of cost function combining energy use and indoor exposure to PM2.5 and ozone

  2018cites this paper
• Cost-effectiveness analysis in cardiac surgery: A review of its concepts and methodologies.

  2017cites this paper
• Frequency of Stroke After Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting (from an Eleven-Year Statewide Analysis).

  2017cites this paper
• Neutrophil gelatinase associated lipocalin, an early biomarker for diagnosis of acute kidney injury after percutaneous coronary intervention

  2017cites this paper
• Nature, scope and use of economic evaluation of healthcare programmes: with special reference to Pakistan.

  2017cites this paper
• The effect of race on postsurgical ambulatory medical follow-up among United States Veterans.

  2017cites this paper
• Alternative ventilation strategies in U.S. offices: Saving energy while enhancing work performance, reducing absenteeism, and considering outdoor pollutant exposure tradeoffs

  2017cites this paper
• Chest pain after percutaneous coronary intervention in patients with stable angina

  2016cites this paper
• Ambulatory Medical Follow-Up in the Year After Surgery and Subsequent Survival in a National Cohort of Veterans Health Administration Surgical Patients.

  2016cites this paper
• Cost modeling for management strategies of uncomplicated gastroschisis.

  2016cites this paper
• Oxidative stress and myocarditis.

  2016cites this paper
• A systematic review of cost-effectiveness of percutaneous coronary intervention vs. surgery for the treatment of multivessel coronary artery disease in the drug-eluting stent era.

  2016cites this paper
• Surgeon Perception of Risk and Benefit in the Decision to Operate Under Uncertainty

  2016cites this paper
• Heartbeat Optical Coherence Tomography

  2015cites this paper
• Cost effectiveness of nonoperative management versus laparoscopic appendectomy for acute uncomplicated appendicitis.

  2015cites this paper
• Cost-effectiveness of revascularization strategies: the ASCERT study.

  2015cites this paper
• Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy

  2015cites this paper
• The impact of tort reform on intensity of treatment: evidence from heart patients.

  2015cites this paper
• Costs, Quality and Value in Cardiovascular Interventions: Implications for clinical decision-making and policy development

  2015cites this paper
• Dual antiplatelet therapy for PCI: Are we tailored to all?

  2015cites this paper
• Percutaneous coronary invervention versus coronary artery bypass grafting: a meta-analysis.

  2015cites this paper
• Evaluation of long-term clinical and health service outcomes following coronary artery revascularisation in Western Australia (WACARP): a population-based cohort study protocol

  2014influential citation
• Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial

  2014cites this paper
• CORONARY BYPASS SURGERY VERSUS PERCUTANEOUS CORONARY INTERVENTION: COST-EFFECTIVENESS IN IRAN: A STUDY IN PATIENTS WITH MULTIVESSEL CORONARY ARTERY DISEASE

  2014cites this paper
• The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction

  2014cites this paper
• The cost–effectiveness of strategies in coronary artery disease

  2014cites this paper
• 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention

  2013cites this paper
• Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.

  2013cites this paper
• ACCF/AHA Practice Guideline

  2013cites this paper
• Predictors of Neuropsychological Status in Cardiac Patients

  2013cites this paper
• Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice

  2013cites this paper
• 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass

  2012cites this paper
• Drug-Eluting Stents in Multivessel Coronary Artery Disease: Cost Effectiveness and Clinical Outcomes

  2012cites this paper
• The economics of cardiovascular disease in the United States.

  2012cites this paper
• Gesundheitsökonomische Evaluation auf Grundlage von GKV-Routinedaten

  2012cites this paper
• Lung resection for non-small cell lung cancer after prophylactic coronary angioplasty and stenting: short- and long-term results.

  2012cites this paper
• Comparing cost aspects of coronary artery bypass graft surgery with coronary artery stenting.

  2012cites this paper
• Treatment strategies for women with coronary artery disease

  2012cites this paper
• Radiation Dose Management for Fluoroscopically Guided Interventional Medical Procedures

  2012cites this paper
• on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions the American College of Cardiology Foundation/American Heart Association Task Force 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A Report of

  2012cites this paper
• Cardiovascular Angiography and Interventions Association Task Force on Practice Guidelines and the Society for Report of the American College of Cardiology Foundation/American Heart 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention : A

  2012cites this paper
• Evidence-Based Interventional Practice

  2012cites this paper
• 74 – Interventional and Surgical Treatment of Coronary Artery Disease

  2012cites this paper
• Economic outcomes of percutaneous coronary intervention with drug‐eluting stents versus bypass surgery for patients with left main or three‐vessel coronary artery disease: One‐year results from the SYNTAX trial

  2012cites this paper
• 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: Executive Summary

  2012cites this paper
• Emergency management for critical left main coronary artery stenosis.

  2011cites this paper
• Coronary artery bypass graft surgery performance and costs by the Brazilian Public Health System (SUS) in the State of Rio de Janeiro, from 1999 to 2008.

  2011cites this paper
• Risk-benefit trade-offs in revascularisation choices.

  2011cites this paper
• Desempenho e gastos do SUS com revascularizações do miocárdio no Estado do Rio de Janeiro, de 1999 a 2008

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• 2011 ACCF/AHA Coronary Artery Bypass Graft Surgery Data Supplements Data Supplement 1. Anesthetic Considerations Author Drug Number of Patients Number of patients with ≥1 SAE (%) RR (95% CI) P-Value Mortality Number of Patients (%) RR

  2011cites this paper
• Revaskularizace myokardu. Perkutánní koronární intervence a aortokoronární bypass

  2011cites this paper
• Small Molecule–Mediated Activation of the Integrin CD11b/CD18 Reduces Inflammatory Disease

  2011cites this paper
• ACCF/AHA Practice Guideline 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2011cites this paper
• 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

  2011cites this paper
• An Economic Analysis & Comparison of Percutaneous Coronary Intervention & Coronary Artery Bypass Graft Surgery

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesi

  2011cites this paper
• ACCF/AHA/SCAI Practice Guideline 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions

  2011cites this paper
• 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2011cites this paper
• Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease.

  2010cites this paper
• Short and long-term consequences of coronary heart disease - application of register-based data in economic evaluations

  2010cites this paper
• Drug-eluting stents and the use of percutaneous coronary intervention among patients with class I indications for coronary artery bypass surgery undergoing index revascularization: analysis from the NCDR (National Cardiovascular Data Registry).

  2009cites this paper
• Increasing Healthcare Resource Utilization After Coronary Artery Bypass Graft Surgery in the United States

  2009cites this paper
• , Mark in the United States Increasing Healthcare Resource Utilization After Coronary Artery Bypass Graft Surgery

  2009cites this paper
• Repeat intervention after invasive treatment of coronary arteries.

  2009cites this paper
• Computed tomographic coronary angiography for diagnosing stable coronary artery disease: a cost-utility and cost-effectiveness analysis.

  2009cites this paper
• Health Related Quality of Life after Invasive Treatment of Coronary Artery Disease

  2009cites this paper
• Table 2.1, CER 1. Comparative Effectiveness of Management for Gastroesophageal Reflux Disease (GERD): Are the conclusions still valid?

  2009cites this paper
• Global trends in cardiology and cardiothoracic surgery--an opportunity or a threat?

  2009cites this paper
• [Stenting or coronary artery bypass surgery for triple vessel disease?].

  2009cites this paper
• Activity Restrictions and Recovery After Open Chest Surgery: Understanding the Patient's Perspective

  2008cites this paper
• [Myocardial revascularization thirty years after: surgery is still up to date].

  2008cites this paper
• Revascularisation myocardique 30 ans aprs: la chirurgie toujours dactualit

  2008cites this paper
• Future costs in cost effectiveness analysis.

  2008cites this paper
• Coronary angioplasty in drug eluting stent era for the treatment of unprotected left main stenosis compared to coronary artery bypass grafting

  2008cites this paper
• Revascularisation myocardique 30 ans après : la chirurgie toujours d'actualité

  2008cites this paper
• The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.

  2008cites this paper
• Pharmacoeconomics of anticoagulants in acute coronary syndrome and percutaneous coronary intervention.

  2008cites this paper
• Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease

  2008cites this paper
• Impact of age and procedure on resource use for patients with ischemic heart disease.

  2008cites this paper
• Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery

  2007cites this paper
• The pathophysiology and burden of restenosis.

  2007cites this paper
• REVIEWARTICLE Coronary artery stents and non-cardiac surgery

  2007cites this paper
• Clinical trials versus registries in coronary revascularization: which are more relevant?

  2007cites this paper
• Coronary artery stents and non-cardiac surgery.

  2007cites this paper
• Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry.

  2007cites this paper
• Surgical Revascularization Is Associated With Improved Long-Term Outcomes Compared With Percutaneous Stenting in Most Subgroups of Patients With Multivessel Coronary Artery Disease: Results From the Intermountain Heart Registry

  2007cites this paper
• Percutaneous coronary intervention "dominates" coronary artery bypass graft surgery for high-risk patients: good news for patients, a challenge for healthcare planners.

  2006cites this paper
• Lack of efficacy and cost-effectiveness of drug-eluting stents.

  2006cites this paper
• Clinical Interventions in Aging Dovepress Chest Pain after Percutaneous Coronary Intervention in Patients with Stable Angina Yueh-chung Chen

  year unknowncites this paper